Mutations in Pol gene of hepatitis B virus in patients with chronic hepatitis B before and after therapy with nucleoside/nucleotide analogues.

Januszkiewicz-Lewandowska, D; Rucka, A; Kowala-Piaskowska, A; Bereszynska, I; Mozer-Lisewska, I; Zajac-Spychala, O; Wysocki, J; Nowak, J

Januszkiewicz-Lewandowska, D; Rucka, A; Kowala-Piaskowska, A; Bereszynska, I; Mozer-Lisewska, I; Zajac-Spychala, O; Wysocki, J; Nowak, J.

Acta Virol ; 58(2): 185-9, 2014.

Article in En | MEDLINE | ID: mdl-24957725

Subject(s)

Antiviral Agents/therapeutic use; Gene Products, pol/genetics; Hepatitis B virus/drug effects; Hepatitis B, Chronic/drug therapy; Mutation; Nucleosides/therapeutic use; Nucleotides/therapeutic use; Adult; Aged; Aged, 80 and over; Female; Hepatitis B virus/genetics; Hepatitis B, Chronic/virology; Humans; Male; Middle Aged; Mutation/drug effects; Nucleosides/chemistry; Nucleotides/chemistry; Retrospective Studies; Young Adult

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Gene Products, pol / Hepatitis B virus / Hepatitis B, Chronic / Mutation / Nucleosides / Nucleotides Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Acta Virol Year: 2014 Type: Article

Search on Google

XML

PubMed Links